Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.56 |
| ▸ | TSHR | P16473 | 3/20 | 0.56 |
| ▸ | THRB | P10828 | 2/20 | 0.53 |
| ▸ | TP53 | P04637 | 2/20 | 0.40 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.40 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.38 |
| ▸ | DGKA | P23743 | 1/20 | 0.38 |
| ▸ | MGAM | O43451 | 1/20 | 0.36 |
| ▸ | GAA | P10253 | 1/20 | 0.36 |
| ▸ | SI | P14410 | 1/20 | 0.36 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.36 |
| ▸ | NAAA | Q02083 | 1/20 | 0.33 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4853279 | 0.98 | ALDH1A1 (0.58) | ALDH1A1TSHRTHRBTP53HIF1A | |
| SCHEMBL8195672 | 0.87 | DGKA (0.42) | ALDH1A1TSHRTHRBTP53HIF1A | |
| SCHEMBL4849689 | 0.83 | ALDH1A1 (0.52) | ALDH1A1TSHRTHRBTP53HIF1A | |
| SCHEMBL8896001 | 0.83 | DGKA (0.48) | ALDH1A1TSHRTHRBTP53HIF1A | |
| SCHEMBL8894704 | 0.83 | DGKA (0.48) | ALDH1A1TSHRTHRBTP53HIF1A | |
| SCHEMBL4856244 | 0.83 | TSHR (0.40) | ALDH1A1TSHRTHRBTP53HIF1A | |
| SCHEMBL3879046 | 0.82 | ALDH1A1 (0.60) | ALDH1A1TSHRTHRBTP53HIF1A | |
| SCHEMBL181390 | 0.82 | ALDH1A1 (0.60) | ALDH1A1TSHRTHRBTP53HIF1A | |
| SCHEMBL2303872 | 0.82 | ALDH1A1 (0.60) | ALDH1A1TSHRTHRBTP53HIF1A | |
| SCHEMBL5411907 | 0.82 | ALDH1A1 (0.60) | ALDH1A1TSHRTHRBTP53HIF1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7329694-B2 | Ocular lens | JOHNSON & JOHNSON VISION CARE, INC. (US) | 2008-02-12 | — | — | US | disclosed |
| EP-1445641-B1 | OCULAR LENS | JOHNSON & JOHNSON VISION CARE (US) | 2007-10-03 | — | — | EP | disclosed |
| US-20040201820-A1 | Ocular lens | JOHNSON & JOHNSON VISION CARE, INC. | 2004-10-14 | — | — | US | disclosed |
| US-20040198938-A1 | Monomers, polymers and ophthalmic lenses | JOHNSON & JOHNSON VISION CARE, INC. | 2004-10-07 | — | — | US | disclosed |
| EP-1445641-A1 | OCULAR LENS | Johnson & Johnson Vision Care, Inc. (US) | 2004-08-11 | — | — | EP | disclosed |
| EP-1424339-A1 | MONOMERS, POLYMERS AND OPHTHALMIC LENSES | Johson & Johnson Vision Care Inc. (US) | 2004-06-02 | — | — | EP | disclosed |
| US-4211696-A | Disperse monoazo dyestuffs derived from 3,5-dinitro-2-amino thiophene as disazo component and an arylamine coupling component | IMPERIAL CHEMICAL INDUSTRIES LIMITED (GB) | 1980-07-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040198938-A1 | Monomers, polymers and ophthalmic lenses | LOXL1, CRYAA, UACA | ALDH1A1 1939/4885TSHR 4300/4885THRB 3917/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.